Latest news
Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path - Fierce PharmaFierce Pharma · Mon, 10 Aug 2026 20:40:16 GMTOrion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 13:36:28 GMTThese 5 walking tips can help you burn more fat without increasing your distance - Women's HealthWomen's Health · Thu, 06 Aug 2026 09:22:53 GMT